Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Carcinoma, Basal Cell

sorafenib has been researched along with Carcinoma, Basal Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kitamura, S; Maeda, T; Miyamoto, K; Yanagi, T1
Breaker, K; Flaig, IP; Flaig, TW; La Rosa, FG; Naam, M1
Degen, A; Gutzmer, R; Hauschild, A; Kapp, A; Satzger, I; Voelker, B1

Reviews

2 review(s) available for sorafenib and Carcinoma, Basal Cell

ArticleYear
Skin cancer associated with the use of sorafenib and sunitinib for renal cell carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:7

    Topics: Adult; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Sorafenib; Sunitinib

2013
Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?
    Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:3

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Female; Humans; Male; Melanoma; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin Neoplasms; Sorafenib

2010

Other Studies

1 other study(ies) available for sorafenib and Carcinoma, Basal Cell

ArticleYear
Sorafenib-Related Basal Cell Carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 09-01, Volume: 47, Issue:9

    Topics: Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Liver Neoplasms; Male; Sorafenib

2021